SCHEMBL5502928

SCHEMBL5502928

CC(C)(C)OC(=O)c1nc(N2CCNCC2)nc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
HPGD P15428 1/20 0.53
HTR2A P28223 5/20 0.51
KDM4E B2RXH2 2/20 0.51
TSHR P16473 1/20 0.51
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
NCF1 P14598 4/20 0.47
ADRB2 P07550 2/20 0.47
ADRB1 P08588 2/20 0.47
ACACB O00763 1/20 0.47
ACACA Q13085 1/20 0.47
PRKCB P05771 1/20 0.44
PRKCA P17252 1/20 0.44
PRKCH P24723 1/20 0.44
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCD Q05655 1/20 0.44
HTR6 P50406 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5502143 0.83 NCF1 (0.50) ALDH1A1HPGDHTR2AKDM4ETSHR
SCHEMBL5502924 0.80 KDM4E (0.52) ALDH1A1KDM4ETSHRMEN1KMT2A
SCHEMBL6218194 0.73 HTR4 (0.50) ACACBACACA
SCHEMBL9216241 0.73 ALDH1A1 (0.62) ALDH1A1HPGDHTR2AKDM4ETSHR
SCHEMBL5637369 0.73 KDM4E (0.47) ALDH1A1KDM4EMEN1KMT2ANCF1
SCHEMBL27476078 0.72 ALDH1A1 (0.51) ALDH1A1HPGDHTR2AKDM4ETSHR
SCHEMBL30777649 0.71 ADRB1 (0.49) HTR2AADRB1HTR6
SCHEMBL8219392 0.71 ADRB1 (0.49) HTR2AADRB1HTR6
Acetic Acid SCHEMBL27476079 0.71 ALDH1A1 (0.53) ALDH1A1HPGDHTR2AKDM4ETSHR
SCHEMBL11574360 0.71 ALDH1A1 (0.50) ALDH1A1HPGDHTR2AKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218353-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA UK LTD (GB) 2007-10-17 EP disclosed
EP-1272185-B1 USE OF QUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ASTRAZENECA AB (SE) 2005-07-27 EP disclosed